- Report
- May 2024
- 186 Pages
Global
From €3217EUR$3,374USD£2,742GBP
€3574EUR$3,749USD£3,046GBP
- Report
- March 2024
- 199 Pages
Global
From €3217EUR$3,374USD£2,742GBP
€3574EUR$3,749USD£3,046GBP
- Report
- January 2024
- 150 Pages
Global
From €5672EUR$5,950USD£4,835GBP
- Report
- February 2024
- 175 Pages
Global
From €4767EUR$5,000USD£4,063GBP
- Report
- October 2023
- 150 Pages
Global
From €2382EUR$2,499USD£2,031GBP
- Report
- June 2024
- 194 Pages
Global
From €4719EUR$4,950USD£4,022GBP
- Clinical Trials
- April 2024
- 250 Pages
Global
From €2860EUR$3,000USD£2,438GBP
- Report
- April 2024
- 152 Pages
Global
From €3766EUR$3,950USD£3,210GBP
- Report
- May 2024
- 182 Pages
Global
From €4671EUR$4,900USD£3,982GBP
- Report
- October 2023
- 190 Pages
Global
From €4671EUR$4,900USD£3,982GBP
- Report
- April 2024
- 115 Pages
Global
From €4290EUR$4,500USD£3,657GBP
- Report
- February 2024
- 175 Pages
Global
From €4767EUR$5,000USD£4,063GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1907EUR$2,000USD£1,625GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1907EUR$2,000USD£1,625GBP
- Report
- February 2024
- 110 Pages
Global
From €4528EUR$4,750USD£3,860GBP
- Report
- March 2024
- 200 Pages
Global
From €3956EUR$4,150USD£3,372GBP
- Report
- April 2022
- 191 Pages
Global
From €3036EUR$3,185USD£2,588GBP
€4338EUR$4,550USD£3,697GBP
- Report
- April 2023
- 115 Pages
Global
From €4528EUR$4,750USD£3,860GBP
- Report
- April 2023
- 240 Pages
Global
From €3337EUR$3,500USD£2,844GBP
- Report
- June 2022
- 95 Pages
Global
From €3766EUR$3,950USD£3,210GBP
The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more